Gene · 6009
Papers4,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host Cell-dependent Modulatory Role of Ras Homolog Enriched in Brain-Like-1 (RhebL1) Protein in Influenza A/NWS/33 Virus-infected Mammalian Cells. | Front Biosci (Landmark Ed) | 2024 | 38538289 | PubTator, text mining | PubMed |
The Absence of Intra-Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study. | Adv Sci (Weinh) | 2024 | 38498682 | PubTator, text mining | PubMed |
| Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies. | Neurol Genet | 2024 | 38496361 | PubTator, text mining | PubMed |
| L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma. | Mod Pathol | 2024 | 38460672 | PubTator, text mining | PubMed |
| An autophagy-associated diagnostic signature based on peripheral blood for antibody-mediated rejection in renal transplantation. | Transpl Immunol | 2024 | 38452984 | PubTator, text mining | PubMed |
| Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling. | Int J Mol Sci | 2024 | 38338768 | PubTator, text mining | PubMed |
| Translation regulation in response to stress. | FEBS J | 2024 | 38308808 | PubTator, text mining | PubMed |
| CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway. | iScience | 2024 | 38303702 | PubTator, text mining | PubMed |
| Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors. | Br J Cancer | 2024 | 38278976 | PubTator, text mining | PubMed |
| Rapamycin-sensitive mechanisms confine the growth of fission yeast below the temperatures detrimental to cell physiology. | iScience | 2024 | 38269097 | PubTator, text mining | PubMed |
| Targeting the Metabolic Paradigms in Cancer and Diabetes. | Biomedicines | 2024 | 38255314 | PubTator, text mining | PubMed |
| The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. | Chem Sci | 2024 | 38239681 | PubTator, text mining | PubMed |
| THADA inhibits autophagy and increases 5-FU sensitivity in gastric cancer cells via the PI3K/AKT/mTOR signaling pathway. | Iran J Basic Med Sci | 2024 | 38234670 | PubTator, text mining | PubMed |
| Amino acid metabolism in tumor biology and therapy. | Cell Death Dis | 2024 | 38218942 | PubTator, text mining | PubMed |
| TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex. | Nat Commun | 2024 | 38195686 | PubTator, text mining | PubMed |
| Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness. | J Transl Med | 2024 | 38191367 | PubTator, text mining | PubMed |
| Kinetic modeling of leucine-mediated signaling and protein metabolism in human skeletal muscle. | iScience | 2024 | 38188514 | PubTator, text mining | PubMed |
| Advances in invasive micropapillary carcinoma of the breast research: A review. | Medicine (Baltimore) | 2024 | 38181281 | PubTator, text mining | PubMed |
| Inhibition of phosphatidylinositol 3-kinase catalytic subunit alpha by miR-203a-3p reduces hypertrophic scar formation via phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway. | Burns Trauma | 2024 | 38179473 | PubTator, text mining | PubMed |
| A new physiological medium uncovers biochemical and cellular alterations in Lesch-Nyhan disease fibroblasts. | Mol Med | 2024 | 38172668 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6009/papers?page=7